The BSE benchmark index is yet to give any indication on the monthly Fibonacci charts.
The 50-share NSE Nifty settled lower by 76.05 points, or 0.88 per cent, at 8,615.25
In an hour-long chat on rediff.com on Thursday, A K Prabhakar, senior VP and Head -- Equity Research (Retail), Anand Rathi Financial Services Ltd, discussed the best stocks to put the investors' money in.
Domestic market is losing its trend to rate sensitive stocks post the announcement of the new RBI governor who is likely to maintain a cautious stance on interest rate cut
Sensex rises, Nifty ends at record high; RIL shares rally.
The 50-issue Nifty fell 29.60 points or 0.34 per cent to close at 8,642.55
Sectoral performance was mixed with media and PSU banking stocks attracting buyer interest and healthcare, FMCG and metal stocks bearing the brunt of the bears
BHEL down around 2.4% and Bharti Airtel down around 1.6% were other major losers.
Market ended lower for the third straight session led by IT stocks amid downgrade by Citigroup.
.jpg)
Markets ended tad lower with financials declining the most ahead of RBI policy review tomorrow.
Markets recorded their biggest single-day fall since August 1 amid growth concerns in the euro zone.
Market breadth ended weak on the BSE with 1,838 declines against 1,218 advances.
The Nikkei share average rose 2.6% to close at 15,195.77 points, more than recouping Tuesday's losses.
The sharp fall in the rupee's value against the dollar during the July-September quarter, it turns out, has come as a boon for corporate earnings.
The bias for the Sensex is likely to remain bearish as long as the index sustains below 18,900-odd levels. On the downside, the index could slide to 17,300-odd levels
BSE Sensex ended at 25,549.72 up by 321 points or 1.27% and the Nifty ended 7624.40 up by 97.75 points or 1.30%.
Sensex closed the day 416 points higher.
The 50-share NSE Nifty was trading lower by 24 points.
Bank shares were the top gainer in early trades with Bank of Baroda up over 4%.
Participants are keeping an eye on the Winter Session of Parliament, which started today, and US fiscal policies to be followed by President-elect Donald Trump
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
Top gainers among the S&P BSE Sensex include GAIL, Dr Reddy's Laboratories and Bharti Airtel, all edging up by 1% in late morning deals
Tracking gains in bluechip stocks, investors were also seen building up position in broader markets, lifting the small-cap and mid-cap indices by 0.83 and 0.15 per cent
Earning woes drag markets lower; TCS, HUL lead fall.
Investors will maintain a cautious stance.
The 30-share Sensex is down 359 points at 26,378 and the Nifty has dropped 78 points to trade at 7,883
The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines
An innovator creates intellectual property for a need no one knows exists, says Chandru Chawla.
The S&P BSE Sensex dropped 1 points to end at 26,396 and the Nifty50 slipped 2 points to end at 8,109.
The 30-share Sensex ended higher by 46 points at 26,360 and the 50-share Nifty gained 16 points at 7,891.
Markets ended lower for the third straight day on Tuesday weighed down by profit taking in rate sensitives with bank shares leading the decline after hopes of rate cut by the central bank faded.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Sensex ended at 26,272 up 125 points and Nifty ended at 7,831 up by 35 points.
In the broader market, BSE midcap and BSE smallcap indices underperformed the larger counterparts and ended flat with a negative bias.
The S&P BSE Sensex ended 80 points up at 23,789 while the Nifty50 closed at 7,235, up 24 points.
While the government's demonetisation move is aimed at curbing under-invoicing, the worry was that retailers would de-stock in the short term, impacting sales.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
India had been engaged in a contentious battle with the US over the issue, especially in the pharmaceutical sector.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
Markets recovered in late trades, amid firm European cues, led by rebound in financials and gains in IT shares.
